...
首页> 外文期刊>Japanese Journal of Pharmacology >Close Correlation between Nitric Oxide (NO) Formation from NO Releasers and the Biological Activities of These Agents in Rats
【24h】

Close Correlation between Nitric Oxide (NO) Formation from NO Releasers and the Biological Activities of These Agents in Rats

机译:一氧化氮释放剂形成的一氧化氮(NO)与这些物质在大鼠中的生物学活性之间密切相关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(18) Cited-By(5) The aim of this study was to clarify the difference in the profiles of nitric oxide (NO) formation of three NO releasers and to examine the correlation between NO formation from these drugs and their biological activities in rats. (±)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409) and 3-morpholinosydnonimine (SIN-1) spontaneously generated nitrite, an oxidative product of NO, in sodium phosphate buffer (PB) solution. On the other hand, sodium nitroprusside (SNP) did not generate nitrite. The rank order of the concentrations of nitrite generated was SIN-1 › FK409 » SNP. In biological studies using rats, these drugs showed anti-platelet effects and in vitro vasorelaxant and hypotensive effects with potencies in the rank order of FK409 › SIN-1 › SNP and SNP › FK409 › SIN-1, respectively. These drugs generated nitrite with concentrations in the rank order of FK409 › SIN-1 › SNP and SNP › FK409 › SIN-1 in rat plasma and in PB solution with L-cysteine (Cys), respectively. In conclusion, three NO releasers liberate NO with NO-releasing rates of different rank orders under different incubation conditions, and the anti-platelet effects and vasorelaxant and hypotensive effects of these NO releasers closely correlate with NO formation from the compounds in the plasma and PB solution with Cys, respectively, but not with that in PB solution without Cys.
机译:参考文献(18)被引用人(5)这项研究的目的是阐明三种NO释放剂的一氧化氮(NO)形成概况的差异,并研究这些药物中NO的形成与其生物学活性之间的相关性。大鼠。 (±)-(E)-乙基-2-[((E)-羟基亚氨基)-5-硝基-3-己烯酰胺(FK409)和3-吗啉代亚胺(SIN-1)自发生成亚硝酸盐(NO的氧化产物)磷酸钠缓冲液(PB)溶液。另一方面,硝普钠(SNP)不会产生亚硝酸盐。生成的亚硝酸盐浓度的等级顺序为SIN-1› FK409&raquo SNP。在使用大鼠的生物学研究中,这些药物分别显示出抗血小板作用以及体外血管舒张和降压作用,其效力分别为FK409› SIN-1› SNP和SNP› FK409› SIN-1。这些药物在大鼠血浆和含有L-半胱氨酸(Cys)的PB溶液中分别产生浓度分别为FK409› SIN-1› SNP和SNP› FK409› SIN-1的亚硝酸盐。综上所述,在不同的培养条件下,三种NO释放剂释放NO的速率不同,释放顺序不同,这些NO释放剂的抗血小板作用,血管舒张和降压作用与血浆和PB化合物中NO的生成密切相关。分别使用Cys的溶液,但不使用Cys的PB解决方案中的溶液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号